APA (7th ed.) Citation

Li, J., Ge, J., Chen, T., Cao, J., He, X., Wang, S., . . . Li, Z. (2025). Efficacy and safety of selinexor-based regimens as first-line treatments for elderly patients with diffuse large B-cell lymphoma: A real-world study. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14295-6

Chicago Style (17th ed.) Citation

Li, Jing, et al. "Efficacy and Safety of Selinexor-based Regimens as First-line Treatments for Elderly Patients with Diffuse Large B-cell Lymphoma: A Real-world Study." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14295-6.

MLA (9th ed.) Citation

Li, Jing, et al. "Efficacy and Safety of Selinexor-based Regimens as First-line Treatments for Elderly Patients with Diffuse Large B-cell Lymphoma: A Real-world Study." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14295-6.